Biotechnology, ClinicalTrials.gov, Vaccination, Vaccine, Clinical trial, Immune system
Moderna nabs a BARDA billion as its kick-starts late-stage pandemic vaccine test
Moderna nabs a BARDA billion as its kick-starts late-stage pandemic vaccine test https://t.co/CTh8IZ0dNP https://t.co/ZbXGW7qj4R
OpenModerna has been handed an extra $472 million to run its phase 3 COVID-19 vaccine test.
Moderna nabs a BARDA billion as its kick-starts late-stage pandemic vaccine test https://t.co/CTh8IZ0dNP https://t.co/ZbXGW7qj4R
OpenModerna nabs a BARDA billion as its kick-starts late-stage pandemic vaccine test
Moderna has been handed an extra $472 million to run its phase 3 COVID-19 vaccine test.
We are sorry, we could not find the related article
If you are curious about Biotech Essentials, the Influencers Review and Companies & Industries
Please click on:
Or signup to our newsletters
Covid-19 vaccine tracker updated to include GSK/Sanofi collaboration
By Jeff Craven Currently, there are no FDA-approved therapies or vaccines for SARS-CoV-2, the virus that causes Covid-19. The National Institute of Allergy and Infectious Diseases (NIAID) ...
Moderna delay a snapshot of 'squabbles' with U.S. scientists over COVID-19 vaccine trials: Reuters
Late last week, Stat reported that Moderna would delay the phase 3 study of its COVID-19 vaccine, thanks to changes to the trial’s protocols. Such changes are not uncommon, highlighting ...
Phase 3 Clinical Trial of Investigational Vaccine for COVID-19 Begins
A Phase 3 clinical trial designed to evaluate if an investigational vaccine can prevent symptomatic coronavirus disease 2019 (COVID-19) in adults has begun. The vaccine, known as mRNA-1273, ...
Phase 3 clinical trial of investigational vaccine for COVID-19 begins
Multi-site trial to test candidate developed by Moderna and NIH.
Researchers Publish Encouraging Early Data on COVID-19 Vaccine
People all around the globe are anxiously awaiting development of a safe, effective vaccine to protect against the deadly threat of coronavirus disease 2019 (COVID-19). Evidence is growing ...
Moderna secures almost $500M more as it starts first large-scale US study of coronavirus vaccine
Moderna went from designing a vaccine to a large Phase 3 study in historic time. Now the biotech will test whether its shot can truly help stop coronavirus' spread.
Africa: The Latest in The COVID-19 Vaccine Race
The race is on to find a vaccine to stop the spread of the COVID-19 virus. Countries around the world are using different vaccine technologies to try and find ones that can halt the ...
Covid-19 Vaccine Race, Month 6: First Emergency Use & Phase 3 Trials
We’re now into the sixth month since the genome of the new coronavirus was sequenced. Twelve to 18 months is the soonest…
Five organisations in the race to develop a coronavirus vaccine
Moderna, CanSino, Oxford University, Imperial College London and Inovio are all making progress
Australia to test COVID-19 vaccine
MELBOURNE, Australia, April 15, 2020 /PRNewswire/ -- The first COVID-19 vaccine to be tested outside of the USA, and only the third vaccine clinical trial in the world, will be conducted by ...
US government gives Moderna $483m for COVID-19 vaccine
US federal government backs Moderna in the race to develop coronavirus vaccine, pledging $483m for development and manufacturing scale-up via its BARDA programme
Increasing number of biopharma drugs target COVID-19 as virus spreads
In a flurry of catch-up following the coronavirus outbreak in China, a number of biopharma companies have announced development within the last few weeks to address the ever-spreading ...
COVID-19 vaccine development reported in various countries
A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co., Ltd. (Sinopharm) in Beijing, capital of China, ...
These nine companies are working on coronavirus treatments or vaccines — here’s where things stand
A mix of legacy drugmakers and small startups have stepped forward with plans to develop vaccines or treatments that target the infection caused by the novel...
1st person in US gets experimental coronavirus vaccine
The vaccine was fast-tracked to human trials, but it will still be some time before it's ready for public use.
Here’s what comes next for Moderna’s COVID-19 vaccine — if everything goes right
As the Cambridge biotech readies to launch a clinical trial involving 30,000 people, it will have to deal with the many complications that have undone countless experimental medicines.
Moderna Stock Takes Off After Good News for Its Birth-Defect Vaccine
Shares of the biotech company are up more than 9% on news of progress on the company’s vaccine for cytomegalovirus, a disease that can lead to birth defects.
An updated guide to the coronavirus drugs and vaccines in development
Here’s a guide to some of the most talked-about efforts to treat or prevent coronavirus infection, with details on the science and timeline for each.
Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine
First participants enrolled in Phase 1 portion of clinical trial of NVX‑CoV2373 Preliminary immunogenicity and safety results expected in July 2020 Phase 2 portion to begin promptly ...
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Original Article from The New England Journal of Medicine — An mRNA Vaccine against SARS-CoV-2 — Preliminary Report